awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33419633-DB576AD0-72D6-4A67-B6CC-5DEFAF5F184E
Q33419633-DB576AD0-72D6-4A67-B6CC-5DEFAF5F184E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419633-DB576AD0-72D6-4A67-B6CC-5DEFAF5F184E
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma.
P2860
Q33419633-DB576AD0-72D6-4A67-B6CC-5DEFAF5F184E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419633-DB576AD0-72D6-4A67-B6CC-5DEFAF5F184E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0678d10af11cd13b32a463382ceee8c9f18a2b2f
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.